CN201930394U - Connector of insulin abdominal cavity administration device - Google Patents
Connector of insulin abdominal cavity administration device Download PDFInfo
- Publication number
- CN201930394U CN201930394U CN2010206199317U CN201020619931U CN201930394U CN 201930394 U CN201930394 U CN 201930394U CN 2010206199317 U CN2010206199317 U CN 2010206199317U CN 201020619931 U CN201020619931 U CN 201020619931U CN 201930394 U CN201930394 U CN 201930394U
- Authority
- CN
- China
- Prior art keywords
- administration device
- insulin
- connector
- sealing shroud
- intraperitoneal administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title claims abstract description 42
- 102000004877 Insulin Human genes 0.000 title claims abstract description 21
- 108090001061 Insulin Proteins 0.000 title claims abstract description 21
- 229940125396 insulin Drugs 0.000 title claims abstract description 21
- 210000000683 abdominal cavity Anatomy 0.000 title abstract description 5
- 238000007789 sealing Methods 0.000 claims abstract description 25
- 238000007912 intraperitoneal administration Methods 0.000 claims description 17
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 239000004033 plastic Substances 0.000 claims description 3
- 229920000260 silastic Polymers 0.000 claims description 3
- 239000003814 drug Substances 0.000 abstract description 7
- 238000002347 injection Methods 0.000 abstract description 5
- 239000007924 injection Substances 0.000 abstract description 5
- 229920002379 silicone rubber Polymers 0.000 abstract description 4
- 239000004945 silicone rubber Substances 0.000 abstract description 3
- 208000015181 infectious disease Diseases 0.000 abstract description 2
- 230000000903 blocking effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 3
- 238000010254 subcutaneous injection Methods 0.000 description 3
- 239000007929 subcutaneous injection Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229940126701 oral medication Drugs 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Images
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
The utility model relates to a connector of an insulin abdominal cavity administration device, which is characterized by comprising a tube seat, a locking nut and a sealing sleeve, wherein the locking nut is connected to the exterior of one end of the tube seat through threads, and the sealing sleeve extending out of one end of the locking nut is arranged in an inner cavity of the tube seat in an interference fit way. The connector has the following advantages: when a patient uses the abdominal cavity administration device, a medicament injection port is connected with the locked silicone rubber sealing sleeve of the connector, thereby not only blocking a medicament inlet and preventing infection, but also enabling an injection needle head to inject a medicament conveniently; furthermore, the silicon rubber sealing sleeve can be replaced periodically. The connector is simple in structure and convenient to operate and use, and is sanitary, safe and reliable.
Description
Technical field
This utility model belongs to technical field of medical instruments, particularly relates to a kind of insulin intraperitoneal administration device connector.
Background technology
Control of diabetes patient's blood sugar concentration generally adopts dual mode, the repeatedly subcutaneous injection of insulin of the first, promptly once a day or for several times carry out subcutaneous injection of insulin, during the subcutaneous injection administration, the peripheral blood circulation insulin concentration is higher than the result of liver insulin concentration, does not meet normal physiological condition.It two is to adopt oral drug therapy, though oral drugs can meet physiological condition from intestinal absorption, oral formulations can not be for a long time accurate blood sugar control effect.Continuous development along with the medical science technology, the therapy of intraperitoneal administration is approved gradually and is adopted, intraperitoneal administration can be absorbed very soon and enter patient's hepatic portal vein and enter liver, forms the Concentraton gradient that the liver insulin concentration is higher than peripheral circulation, more meets the normal physiological model of action.And can significantly reduce insulin dosage, and be difficult for taking place hypoglycemia, more above-mentioned dual mode improves sugar, the unusual better effects if of lipid metabolism.Intraperitoneal administration is meant and adopts insulin pump to place the patient external, administering mode at abdominal cavity heeling-in microtubular adopts high strength stability biocompatible materials to make the soft catheter of diameter in 0.5 millimeter, by the end importing patient body abdominal cavity of invasive methods with microtubular, the other end places external as the medicine injection port.At present, still there is not the special-purpose adapter that uses with insulin intraperitoneal administration matched with devices.
Summary of the invention
This utility model provides a kind of insulin intraperitoneal administration device connector that can use with the intraperitoneal administration matched with devices reasonable, easy for operation of constructing for solving the technical problem that exists in the known technology.
The technical scheme that this utility model is taked for the technical problem that exists in the solution known technology is: insulin intraperitoneal administration device connector, it is characterized in that: comprise base, locknut and sealing shroud, described base one end external screw-thread is connected with locknut, and the interference of base inner chamber is fitted with the sealing shroud that extends locknut one end.
This utility model can also adopt following technical scheme:
The tapered structure of described sealing shroud one end, the other end is a flat segments.
Be shaped on a through hole on the described sealing shroud axial direction.
The equipped end of described base inner chamber and sealing shroud is the conical cavity structure, and the base other end is shaped on female Luer.
Described sealing shroud adopts silastic material to make.
Described base and locknut all adopt hard PC plastic production.
Advantage and the good effect that the utlity model has are: because this utility model adopts technique scheme, when the patient uses the intraperitoneal administration device, the silicone rubber seal cover that the medicine injection port can be connected the locking of this connector belt, so not only can seal the medicine inlet protects from infection, also can be convenient to the injection needle injectable drug, the silicone rubber seal cover can regularly replace.This connector construction is simple, easy for operation, and safe and sanitary is reliable.
Description of drawings
Fig. 1 is a structural representation of the present utility model.
Among the figure: 1, base; 1-1,, conical cavity; 2, locknut; 3, sealing shroud; 4, microtubular.
The specific embodiment
For further understanding summary of the invention of the present utility model, characteristics and effect, exemplify following examples now, and conjunction with figs. is described in detail as follows:
See also Fig. 1, insulin intraperitoneal administration device connector comprises base 1, locknut 2 and sealing shroud 3.Described base one end external screw-thread is connected with locknut 2, and the interference of base inner chamber is fitted with the sealing shroud 3 that extends locknut one end.The tapered structure of described sealing shroud 3 one ends, the other end is a flat segments.The equipped end of base inner chamber and sealing shroud is conical cavity 1-1, and the base other end is shaped on female Luer.Be shaped on a through hole that is used to be communicated with microtubular 4 on the described sealing shroud axial direction, the diameter of described through hole is 0.5mm.Described sealing shroud 3 adopts silastic material to make, and described base 1 and locknut 2 all adopt hard PC plastic production.
During use, microtubular 4 is inserted the sealing shroud intermediate throughholes from flat segments one end, with base and locknut locking, sealing shroud is promptly compacted, with being tightly connected of realization and microtubular then.
Claims (6)
1. insulin intraperitoneal administration device connector, it is characterized in that: comprise base, locknut and sealing shroud, described base one end external screw-thread is connected with locknut, and the interference of base inner chamber is fitted with the sealing shroud that extends locknut one end.
2. insulin intraperitoneal administration device connector according to claim 1 is characterized in that: the tapered structure of described sealing shroud one end, the other end is a flat segments.
3. insulin intraperitoneal administration device connector according to claim 2 is characterized in that: be shaped on a through hole on the described sealing shroud axial direction.
4. insulin intraperitoneal administration device connector according to claim 1 is characterized in that: the equipped end of described base inner chamber and sealing shroud is the conical cavity structure, and the base other end is shaped on female Luer.
5. according to claim 1 or 2 or 3 described insulin intraperitoneal administration device connectors, it is characterized in that: described sealing shroud adopts silastic material to make.
6. insulin intraperitoneal administration device connector according to claim 1 is characterized in that: described base and locknut all adopt hard PC plastic production.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010206199317U CN201930394U (en) | 2010-11-23 | 2010-11-23 | Connector of insulin abdominal cavity administration device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010206199317U CN201930394U (en) | 2010-11-23 | 2010-11-23 | Connector of insulin abdominal cavity administration device |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN201930394U true CN201930394U (en) | 2011-08-17 |
Family
ID=44441936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010206199317U Expired - Lifetime CN201930394U (en) | 2010-11-23 | 2010-11-23 | Connector of insulin abdominal cavity administration device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN201930394U (en) |
-
2010
- 2010-11-23 CN CN2010206199317U patent/CN201930394U/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102327656A (en) | Disposable array miniature injection needle head | |
| CN101224315A (en) | Infusion method of multiple medicine and velocity and device thereof | |
| CN104208770B (en) | Tube sealing injection device avoiding venous indwelling needle blockage | |
| CN201930394U (en) | Connector of insulin abdominal cavity administration device | |
| CN204910455U (en) | Medical multicavity associated drainage catheter | |
| CN215780558U (en) | Improved disposable continuous infusion pump suitable for transarterial administration | |
| CN102488958A (en) | Implanted chemical therapy device for abdominal cavity | |
| CN201283161Y (en) | Disposal cotton swab for nasal administration | |
| CN211751504U (en) | Miniature micro-dispensing-free infusion pump | |
| CN201067576Y (en) | Nasal feeding food injector | |
| CN201200664Y (en) | Novel two-chamber medicament sustained-release infusion device | |
| CN202342607U (en) | Disposable array type mini injection needle | |
| CN108904970A (en) | A kind of multipurpose medical anti-reflective stream connector | |
| CN205055185U (en) | Ally oneself with micropin inserting needle sleeve or frame more and ally oneself with syringe more | |
| CN202892637U (en) | Infant anus pushing-injection machine | |
| WO2006108336A1 (en) | Implantable administrating catheter | |
| CN201015667Y (en) | Injection and transfusion dual-purpose scalp needle | |
| CN110680998A (en) | Adjustable injector | |
| CN206587269U (en) | intraperitoneal administration device | |
| CN201750930U (en) | Rectal administration apparatus | |
| CN219462278U (en) | Rectal tube drug delivery device | |
| CN112169083B (en) | Needleless administration joint with neutral pressure | |
| CN203694262U (en) | Cardiovascular injecting device for radiography medicine | |
| CN217311620U (en) | Bladder perfusion tee joint stable in connection | |
| CN218129459U (en) | Disposable long catheter trocar indwelling device capable of preventing blood seepage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20110817 |